Structure of the Ulster Strain Newcastle Disease Virus Hemagglutinin-Neuraminidase Reveals Auto-Inhibitory Interactions Associated with Low Virulence

PLoS Pathogens

Volumn 8, Issue 8, 2012, Pages

  Yuan, Ping ^a   Paterson, Reay G ^b   Leser, George P ^b   Lamb, Robert A ^b   Jardetzky, Theodore S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DIMER; HEMAGGLUTININ NEURAMINIDASE; SIALIC ACID; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HYDROPHOBICITY; MEMBRANE FUSION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRION; VIROGENESIS; VIRUS STRAIN; VIRUS VIRULENCE;

CRYSTALLOGRAPHY, X-RAY; HELA CELLS; HN PROTEIN; HUMANS; NEWCASTLE DISEASE VIRUS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS;

NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

EID: 84866152545     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002855     Document Type: Article

References (46)

1. Lamb RA, Parks GD (2007) Paramyxoviridae: The viruses and their replication. In: Fields Virology. Fifth ed. Knipe DM, Howley PM, editors. Wolters Kluwer Lippincott WIlliams & Wilkins. 1449-1496.
2. Alexander DJ, (2011) Newcastle disease in the European Union 2000 to 2009. Avian Pathol 40: 547-558.
3. Alexander DJ, (2000) Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 19: 443-462.
4. Zamarin D, Palese P, (2012) Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol 7: 347-367.
5. Lamb RA, Jardetzky TS, (2007) Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 17: 427-436.
6. Smith EC, Popa A, Chang A, Masante C, Dutch RE, (2009) Viral entry mechanisms: the increasing diversity of paramyxovirus entry. Febs J 276: 7217-7227.
7. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, et al. (2004) Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78: 12877-12887.
8. Karron RA, Buonagurio DA, Georgiu AF, Whitehead SS, Adamus JE, et al. (1997) Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A 94: 13961-13966.
9. Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, et al. (2011) Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A 108: 14920-14925.
10. Bose S, Welch BD, Kors CA, Yuan P, Jardetzky TS, et al. (2011) Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol 85: 12855-12866.
11. Plemper RK, (2011) Cell Entry of Enveloped Viruses. Curr Opin Virol 1: 92-100.
12. Garten W, Kohama T, Klenk HD, (1980) Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide. J Gen Virol 51: 207-211.
13. Millar NS, Chambers P, Emmerson PT, (1988) Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol 69 (Pt 3): 613-620.
14. Nagai Y, Klenk HD, (1977) Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology 77: 125-134.
15. Nagai Y, Klenk HD, Rott R, (1976) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494-508.
16. Toyoda T, Sakaguchi T, Imai K, Inocencio NM, Gotoh B, et al. (1987) Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242-247.
17. Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD, et al. (2004) The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 78: 4176-4184.
18. Romer-Oberdorfer A, Werner O, Veits J, Mebatsion T, Mettenleiter TC, (2003) Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J Gen Virol 84: 3121-3129.
19. Gorman JJ, Nestorowicz A, Mitchell SJ, Corino GL, Selleck PW, (1988) Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. J Biol Chem 263: 12522-12531.
20. Sakaguchi T, Toyoda T, Gotoh B, Inocencio NM, Kuma K, et al. (1989) Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169: 260-272.
21. Sato H, Hattori S, Ishida N, Imamura Y, Kawakita M, (1987) Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains. Virus Res 8: 217-232.
22. Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, et al. (2005) Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure (Camb) 13: 803-815.
23. Yuan P, Leser GP, Demeler B, Lamb RA, Jardetzky TS, (2008) Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology 378: 282-291.
24. Bousse TL, Taylor G, Krishnamurthy S, Portner A, Samal SK, et al. (2004) Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J Virol 78: 13351-13355.
25. Takimoto T, Taylor GL, Crennell SJ, Scroggs RA, Portner A, (2000) Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology 270: 208-214.
26. Crennell S, Takimoto T, Portner A, Taylor G, (2000) Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7: 1068-1074.
27. Melanson VR, Iorio RM, (2006) Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol 80: 623-633.
28. Paterson RG, Lamb RA, (1990) Conversion of a class II integral membrane protein into a soluble and efficiently secreted protein: multiple intracellular and extracellular oligomeric and conformational forms. J Cell Biol 110: 999-1011.
29. Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, et al. (2004) Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol 78: 3733-3741.
30. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, et al. (2004) Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol 335: 1343-1357.
31. Mishin VP, Watanabe M, Taylor G, Devincenzo J, Bose M, et al. (2010) N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol 84: 3094-3100.
32. Porotto M, Salah Z, Devito I, Talekar A, Palmer SG, et al. (2012) The second receptor binding site of the globular head of the Newcastle disease virus (NDV) hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol 86: 5730-5741.
33. Mahon PJ, Mirza AM, Iorio RM, (2011) Role of the two sialic acid binding sites on the newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J Virol 85: 12079-12082.
34. Glickman RL, Syddall RJ, Iorio RM, Sheehan JP, Bratt MA, (1988) Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol 62: 354-356.
35. Romer-Oberdorfer A, Veits J, Werner O, Mettenleiter TC, (2006) Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN. Avian Dis 50: 259-263.
36. Scanlon DB, Corino GL, Shiell BJ, Della-Porta AJ, Manvell RJ, et al. (1999) Pathotyping isolates of Newcastle disease virus using antipeptide antibodies to pathotype-specific regions of their fusion and hemagglutinin-neuraminidase proteins. Arch Virol 144: 55-72.
37. Niwa H, Yamamura K, Miyazaki J, (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
38. Aricescu AR, Lu W, Jones EY, (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62: 1243-1250.
39. Paterson RG, Takeda M, Ohigashi Y, Pinto LH, Lamb RA, (2003) Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology 306: 7-17.
40. Otwinowski Z, Minor W, (1997) Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology: Macromolecular Crystallography, part A. Academic Press. pp. 307-326.
41. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
42. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
43. CCP4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 50: 760-763.
44. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58: 1948-1954.
45. Corpet F, (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16: 10881-10890.
46. Vaguine AA, Richelle J, Wodak SJ, (1999) SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. Acta Crystallogr D Biol Crystallogr 55: 191-205.